Drying and inflammation of the conjunctiva as a result of insufficient lacrimal secretion. When found in association with XEROSTOMIA and polyarthritis, it is called SJOGREN'S SYNDROME.
Simultaneous inflammation of the cornea and conjunctiva.
The fluid secreted by the lacrimal glands. This fluid moistens the CONJUNCTIVA and CORNEA.
The tear-forming and tear-conducting system which includes the lacrimal glands, eyelid margins, conjunctival sac, and the tear drainage system.
Infectious diseases of cattle, sheep, and goats, characterized by blepharospasm, lacrimation, conjunctivitis, and varying degrees of corneal opacity and ulceration. In cattle the causative agent is MORAXELLA (MORAXELLA) BOVIS; in sheep, MYCOPLASMA; RICKETTSIA; CHLAMYDIA; or ACHOLEPLASMA; in goats, RICKETTSIA.
Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.
The mucous membrane that covers the posterior surface of the eyelids and the anterior pericorneal surface of the eyeball.
Measurement of light given off by fluorescein in order to assess the integrity of various ocular barriers. The method is used to investigate the blood-aqueous barrier, blood-retinal barrier, aqueous flow measurements, corneal endothelial permeability, and tear flow dynamics.
Green dyes containing ammonium and aryl sulfonate moieties that facilitate the visualization of tissues, if given intravenously. They have mostly been used in the study of kidney physiology.
A phthalic indicator dye that appears yellow-green in normal tear film and bright green in a more alkaline medium such as the aqueous humor.
Conjunctivitis due to hypersensitivity to various allergens.
Dryness of the eye surfaces caused by deficiency of tears or conjunctival secretions. It may be associated with vitamin A deficiency, trauma, or any condition in which the eyelids do not close completely.
Decreased salivary flow.
A bright bluish pink compound that has been used as a dye, biological stain, and diagnostic aid.
A species of gram-negative, aerobic BACTERIA found in the human NASOPHARYNX; SALIVA; and SPUTUM.
Corneal and conjunctival dryness due to deficient tear production, predominantly in menopausal and post-menopausal women. Filamentary keratitis or erosion of the conjunctival and corneal epithelium may be caused by these disorders. Sensation of the presence of a foreign body in the eye and burning of the eyes may occur.
Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS.
A genus of gram-negative, aerobic bacteria occurring as rods (subgenus Moraxella) or cocci (subgenus Branhamella). Its organisms are parasitic on the mucous membranes of humans and other warm-blooded animals.
Inflammation, often mild, of the conjunctiva caused by a variety of viral agents. Conjunctival involvement may be part of a systemic infection.
The transparent anterior portion of the fibrous coat of the eye consisting of five layers: stratified squamous CORNEAL EPITHELIUM; BOWMAN MEMBRANE; CORNEAL STROMA; DESCEMET MEMBRANE; and mesenchymal CORNEAL ENDOTHELIUM. It serves as the first refracting medium of the eye. It is structurally continuous with the SCLERA, avascular, receiving its nourishment by permeation through spaces between the lamellae, and is innervated by the ophthalmic division of the TRIGEMINAL NERVE via the ciliary nerves and those of the surrounding conjunctiva which together form plexuses. (Cline et al., Dictionary of Visual Science, 4th ed)
A species of gram-negative, aerobic bacteria that is most frequently isolated from bovine eyes in cases of infectious keratoconjunctivitis (KERATOCONJUNCTIVITIS, INFECTIOUS), but also occurs in unaffected eyes and the nasal cavity of cattle.
The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example.
Respiratory and conjunctival infections caused by 33 identified serotypes of human adenoviruses.
Virus diseases caused by the ADENOVIRIDAE.
Conjunctivitis is an inflammation or infection of the conjunctiva, the transparent membrane that lines the inner surface of the eyelids and covers the white part of the eye, resulting in symptoms such as redness, swelling, itching, burning, discharge, and increased sensitivity to light.
A genus of gram-negative, aerobic, coccoid bacteria whose organisms are part of the normal flora of the oropharynx, nasopharynx, and genitourinary tract. Some species are primary pathogens for humans.
Inflammation of the lacrimal sac. (Dorland, 27th ed)
A species of gram-negative bacteria causing CONJUNCTIVITIS and KERATOCONJUNCTIVITIS in SHEEP and GOATS.
Species of the genus MASTADENOVIRUS, causing a wide range of diseases in humans. Infections are mostly asymptomatic, but can be associated with diseases of the respiratory, ocular, and gastrointestinal systems. Serotypes (named with Arabic numbers) have been grouped into species designated Human adenovirus A-F.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.

Expression of CD40 and CD40 ligand in the human conjunctival epithelium. (1/77)

PURPOSE: CD40 antigen is a membrane receptor that plays a role in the regulation of immune reactions. The expressions of CD40 and CD40 ligand (CD40L) were investigated ex vivo and in vitro in conjunctival epithelial cells, in correlation with HLA DR class H antigen, previously shown to be upregulated in conjunctival inflammatory conditions. METHODS: Impression cytology specimens were collected in 186 patients: 52 normal ones, 65 with keratoconjunctivitis sicca, and 69 with chronic conjunctivitis. Cells were processed for flow cytometry, by using monoclonal antibodies to CD40, CD40L, and HLA DR antigens. Chang conjunctival cells were also used and treated with human recombinant interferon (IFN)-gamma or tumor necrosis factor (TNF)-alpha. CD40, CD40L, and HLA DR expressions were studied by flow cytometry after 24 and 48 hours of treatment. RESULTS: CD40 was found in both normal and pathologic eyes. Quantitation of levels of fluorescence showed a significantly higher expression in pathologic eyes than in normal ones (P < 0.0001). CD40L was variably and inconstantly expressed by conjunctival cells. A strong expression of HLA DR was observed in pathologic eyes, whereas normal eyes showed very low levels (P < 0.0001). Significantly positive correlations were found among CD40, CD40L, and HLA DR levels. Chang conjunctival cells expressed CD40 in basal conditions, whereas CD40L and HLA DR were negative. CD40 expression significantly increased after 24 hours of IFNgamma treatment and after 48 hours' exposure to TNFalpha. These cytokines had no effect on CD40L expression. HLA DR was upregulated after 24 hours of treatment with IFNgamma but remained negative after exposure to TNFalpha. CONCLUSIONS: Human conjunctival epithelial cells normally express CD40 antigen, and, more inconsistently, CD40L. Flow cytometry showed higher expression of these molecules in inflammatory eyes than in normal ones in correlation with class II antigen expression, as well as CD40 and HLA DR upregulation after treatment with proinflammatory cytokines in vitro.  (+info)

Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. (2/77)

PURPOSE: To investigate in impression cytology (IC) specimens the expression of inflammatory and apoptosis-related markers by conjunctival epithelial cells from patients with dry eye as a rationale for treatment with topical cyclosporine. METHODS: Immunologic anomalies were identified at baseline, before treatment with the masked medication, in a homogeneous series of patients with dry eye syndrome, who were enrolled in a large European multicenter clinical trial (Cyclosporin A Dry Eye Study; Allergan, Irvine, CA). IC specimens were collected in 243 patients with moderate to severe keratoconjunctivitis sicca (KCS), with or without Sjogren's syndrome (SS). Fifty normal subjects were separately examined to provide normal control values. Specimens were analyzed in a masked manner by flow cytometry, using antibodies directed to markers of the immune system and/or apoptotic pathway: HLA DR, CD40, CD40 ligand, Fas, and APO2.7. Levels of expression were quantified, and results were compared with those obtained in the 50 normal patients. RESULTS: One hundred sixty-nine specimens were successfully interpreted at baseline, including 41% from patients with SS. A highly significant increase of HLA DR expression by conjunctival cells was found in KCS-affected eyes compared with normal eyes, which did not express this marker or did so very weakly. HLA DR expression in eyes with SS was significantly higher than in KCS-affected eyes without SS. Fas and APO2.7 were found at low levels in all normal and KCS-affected eyes. CD40 and CD40 ligand expressions were significantly increased in eyes with KCS compared with normal eyes. HLA DR, CD40 and Fas were found at significantly higher levels in the SS group than in the non-SS group. CONCLUSIONS. Conjunctival cells from patients with dry eye with moderate to severe KCS, with or without SS, overexpress inflammatory and apoptosis-related markers. Whether inflammation is a primary phenomenon in KCS or is the consequence of repetitive abrasion of the ocular surface after tear film deficiency remains to be determined. These data, nevertheless, support the use of immunomodulatory and/or anti-inflammatory drugs in the treatment of patients with KCS.  (+info)

Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. (3/77)

PURPOSE: Immune-based inflammation has been observed as a common mechanism of keratoconjunctivitis sicca (KCS). In KCS-affected eyes, upregulated expression of HLA DR and various immune- or apoptosis-related markers by conjunctival epithelial cells has been demonstrated in an earlier study, by a technique of flow cytometry in impression cytology (IC) specimens. The purpose of this study was to monitor the effects of topical cyclosporin A on the expression of these markers throughout a 6-month period of treatment. METHODS: Patients with moderate to severe KCS included in a large European multicenter clinical trial (Cyclosporin Dry Eye Study, Allergan, Irvine, CA) underwent collection of IC specimens at baseline, month 3, and month 6. For 6 months, they randomly received 0.05% or 0.1% cyclosporin A or vehicle. Specimens were processed and analyzed in a masked manner by flow cytometry, using monoclonal antibodies directed to HLA DR, CD40, CD40 ligand, Fas, and the apoptotic marker APO2.7. Percentages of positive cells were calculated and levels of expression quantified after conversion into standardized units of fluorescence. RESULTS: One hundred fifty-eight patients had at least two IC specimens available for flow cytometry analysis. HLA DR expression, both in percentage of positive cells and level of expression, was highly significantly reduced after 0.05% and 0.1% cyclosporin A treatment at months 3 and 6 compared with baseline values, whereas vehicle did not induce any change in HLA DR expression over time. The 0.05% and 0.1% cyclosporin emulsions were significantly more effective than the vehicle in reducing HLA DR at months 3 and 6 (0.05%), and at month 6 (0.1%). CD40 expression was significantly reduced at month 3 and partially at month 6, compared with baseline, with no reduction in patients who received the vehicle. CD40 ligand expression also decreased at months 3 and 6 in patients taking both concentrations of cyclosporin A. APO2.7 expression was significantly increased in all three groups, whereas percentage of Fas-positive cells decreased only in patients treated with 0.05% cyclosporin A at months 3 and 6. CONCLUSIONS: Flow cytometry provided an objective technique to monitor the effects of topical cyclosporin A on immune- and apoptosis-related markers in the conjunctival epithelium of patients with KCS enrolled in a large multicenter trial. Topical cyclosporin A strikingly reduced HLA DR and to a lesser extent, other inflammatory and apoptotic markers, whereas the vehicle, used as a control tear substitute, had almost no effect. This study confirms that cyclosporin A may be efficient in reducing conjunctival inflammation in moderate to severe KCS and is consistent with clinical results in this indication.  (+info)

Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model. (4/77)

PURPOSE: To test the hypothesis that beneficial effects of Cyclosporin A (CsA; Sandimmune; Sandoz, Basel, Switzerland) in treating keratoconjunctivitis sicca (KCS) include an effect on the mucin-producing conjunctival goblet cells independent of CsA's effect on lacrimation. METHODS: Keratoconjunctivitis sicca was induced bilaterally in six dogs after removal of orbital and nictitans lacrimal glands. Two weeks after induction of KCS, either 2% CsA or vehicle was applied twice daily to each surgically altered eye until 6 weeks after KCS induction. Eyes of three control dogs without surgically altered eyes were treated twice daily with vehicle only. Incisional biopsy specimens of ventral fornix conjunctiva were collected before gland removal (baseline) and at 2, 4, and 6 weeks after KCS induction. At each sampling time, eyes were photographed, and color images were subsequently graded for degree of conjunctivitis and characteristics of ocular discharge. Intracellular mucin stores in conjunctival epithelia were estimated using computer-assisted morphometry of biopsy specimen cross sections, and clinical and morphometric findings were correlated. RESULTS: Lacrimal gland removal resulted in induction of KCS in dogs by 2 weeks, with mean Schirmer tear test (STT) values of 5 mm/min or less occurring in surgically altered eyes compared with STT values of 22.5 mm/min before surgery and 22.9 mm/min in unaltered control eyes at 2 weeks. In surgically altered eyes, STTs remained low during the 6-week study, independent of topical treatment. Intracellular mucin stores were quantified from conjunctival samples collected from each eye at baseline and 2, 4, and 6 weeks. At 4 and 6 weeks (after 2 and 4 weeks of topical treatment), intraepithelial mucin quantities were significantly greater (P: < 0.05) in CsA-treated KCS eyes (14.4 and 13.1 microm(2)/microm, respectively) compared with pretreatment KCS (7.4 microm(2)/microm) eyes and vehicle-treated KCS eyes (7.3 and 8.5 microm(2)/microm, respectively). KCS eyes treated with CsA had lower conjunctivitis and ocular discharge scores than did vehicle-treated KCS eyes. CONCLUSIONS: Topical 2% CsA restored in vivo conjunctival mucin stores to control levels over a 4-week period, determined by computer-assisted morphometry of sequential conjunctival biopsy specimens from eyes of dogs with surgically induced KCS. Degree of conjunctivitis and severity of mucus discharge were decreased in KCS eyes treated with CsA. Because lacrimal tissues were removed from animals in this study, conjunctival responses occurred independent of lacrimogenic effect(s). These results indicate that restoration of conjunctival goblet cell mucin production, i.e., the balance between synthesis and secretion of mucin glycoproteins, may play an important role in the beneficial effect of CsA in treating KCS.  (+info)

Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. (5/77)

BACKGROUND/AIMS: Autologous serum drops have been reported to be beneficial in keratoconjunctivitis sicca (KCS) and persistent epithelial defects (PED). A clinical pilot study was carried out to examine these potential uses and in vitro toxicity testing on corneal epithelial cell cultures was performed to compare the effect of serum drops with unpreserved hypromellose (hydroxypropylmethylcellulose 0.3%). METHODS: Patients with KCS and PED, unresponsive to conventional treatment were recruited. Patients were examined before treatment, at 1 and 2 weeks after initiation, and then 2 weekly until treatment ceased. Symptoms were assessed at each visit. Clinical examination included Schirmer's test without anaesthesia, rose bengal staining, and fluorescein staining. Epithelial defects were measured with the slit beam. In the laboratory, cultured human corneal epithelial cells were exposed to serum drops and hypromellose, and their viability evaluated with fluorescent viability staining (Calcein AM ethidium homodimer) and an ATP assay. RESULTS: Autologous serum was used in 15 eyes of 13 patients with PED and 11 eyes of nine patients with KCS. In two patients serum drops were started after penetrating keratoplasty (PK). The PKs were performed for perforations secondary to PEDs. Of the 15 eyes with PED, nine healed at a mean of 29 days and six failed. The mean duration of PED before the use of serum drops was 48.2 days. Of the 11 eyes with KCS, six had improved subjective scores and fluorescein scores, and five had improved rose bengal scores after the use of serum drops. For the two patients who used serum eyedrops post-PK, there was a stable and intact epithelium at 1 week. Cessation of serum drops during the postoperative period led to deterioration in the subjective and objective scores in both patients. One developed a PED that responded to reinstitution of serum drops. The morphology and ATP levels of cultured epithelial cells exposed to serum were better maintained than those exposed to hypromellose. CONCLUSION: Autologous serum drops are useful for PED and KCS. This effect may be related to a number of active factors in serum including growth factors, fibronectin, vitamin A, and anti-proteases. In vitro toxicity testing demonstrated that serum drops have reduced toxicity compared with unpreserved hypromellose. Currently regulatory restrictions in the UK have prevented the establishment of a prospective randomised controlled trial examining the efficacy of autologous serum drops for the management of this group of ocular surface disorders.  (+info)

A mouse model of keratoconjunctivitis sicca. (6/77)

PURPOSE: To evaluate the effects of pharmacologic inhibition of aqueous tear production and desiccating environmental stress on aqueous tear production, tear clearance, corneal epithelial permeability, and conjunctival epithelial morphology, proliferation, and conjunctival goblet cell differentiation. METHODS: Aqueous tear production was inhibited by applying transdermal scopolamine (scop) patches to the depilated midtail of female MC, CBA mice. Desiccating environmental stress was created by placing mice in a hood with a continuous airflow blower. Aqueous tear production and volume, tear clearance, and corneal barrier function were compared in four experimental groups: untreated control mice, mice placed in the blower hood, mice treated with a scop patch, and mice treated with a scop patch and blower hood (scop patch + blower). Cotton threads were used to evaluate aqueous tear production and volume. Tear clearance was assessed by fluorometric measurement of collected tear fluid 15 minutes after instillation of 1% sodium fluorescein. Corneal epithelial barrier function was assessed by fluorometric measurement of carboxyfluorescein uptake. Conjunctival morphology and goblet cell density were evaluated in stained histologic sections. Conjunctival epithelial proliferation was assessed by bromodeoxyuridine (BrdU) labeling. RESULTS: Significant decreases in cotton thread wetting and tear clearance were observed in mice treated with a scop patch (P < 0.001) or with a scop patch and blower desiccation (P < 0.001), with a greater reduction in tear clearance in the latter group. Significantly increased corneal carboxyfluorescein uptake was noted in the scop patch group compared with untreated mice (P = 0.05) and in the scop patch + blower group compared with all the other groups (P < 0.0001). Changes in conjunctival epithelial morphology and a significant decrease in conjunctival goblet cell density (P < 0.001) were observed in the scop patch + blower group compared with the untreated control group. The number of proliferating conjunctival epithelial cells was significantly greater in the scop patch + blower group. CONCLUSIONS: Pharmacologic inhibition of tear production in mice is accompanied by ocular surface epithelial changes resembling human keratoconjunctivitis sicca (KCS) that are exacerbated by desiccating environmental stress. Cholinergic stimulated tear production appears to be essential for maintaining a healthy ocular surface.  (+info)

A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren's syndrome patients with xerostomia and keratoconjunctivitis sicca. (7/77)

OBJECTIVE: To evaluate the safety and efficacy of 2 dosages of cevimeline for the treatment of xerostomia and keratoconjunctivitis sicca in patients with Sjogren's syndrome. METHODS: A 12-week double-blind, randomized, placebo-controlled study was performed. Patients were randomly assigned to receive either placebo, 15 mg of cevimeline 3 times daily, or 30 mg of cevimeline 3 times daily. Patients were evaluated at baseline and throughout the study for their global assessment of dryness (mouth, eyes, overall) as well as their subjective assessment of the specific symptoms of dry mouth and dry eyes. Total saliva and tear flow also were measured. RESULTS: Patients taking 30 mg of cevimeline 3 times daily had statistically significant improvements in their subjective global assessment of dry eyes (P = 0.0453), dry mouth (P = 0.0004), and increased salivary flow (P = 0.007). Patients receiving the 30-mg dosage also showed greater objective improvement (increased salivary and lacrimal flow rates, as measured by Schirmer's test) than did patients receiving placebo. Frequently reported adverse events included headache, increased sweating, abdominal pain, and nausea. CONCLUSION: Treatment with cevimeline at a dosage of 30 mg 3 times daily resulted in substantive improvement by increasing the rate of saliva and tear flow in patients with Sjogren's syndrome, as well as improving subjective symptoms of dry mouth, dry eyes, and overall dryness. The 15-mg dosage relieved some symptoms, and both dosages were well tolerated.  (+info)

A new technique for tear film fluorophotometry. (8/77)

AIM: To develop a reliable and objective non-touch technique for determination of tear volume and tear secretion by means of tear film fluorophotometry. METHODS: 10 defined concentrations of sodium fluorescein were given in an artificial chamber and measured by the Fluorotron Master (Coherent Radiation Inc). A calibration line was established and the calibration equation was programmed into the Fluorotron Master computer software. In 28 patients (56 eyes) with dry eye symptoms and 15 volunteers (30 eyes) tear volume and tear secretion were then measured directly without taking a tear sample, using the new technique. RESULTS: The values obtained by the Fluorotron Master measuring 10 defined fluorescein concentrations within an artificial chamber are approximately 100 times lower than the actual concentrations. The calibration line led to a calibration equation: y = 36 + 0.01 x X. The mean tear secretion in 56 eyes of patients with dry eye symptoms was 2.48 microl/min, compared to 3.4 microl/min in healthy volunteers. The difference was statistically significant. Average tear volume was 7.0 microl in patients and 7.2 microl in healthy volunteers with no statistically significant difference. CONCLUSION: The method developed is a simple and reliable non-touch technique without the need for taking a tear sample, which makes the examination faster and more comfortable for the patient.  (+info)

Keratoconjunctivitis Sicca, also known as dry eye syndrome, is a condition characterized by decreased quality and/or quantity of tears to lubricate and nourish the eye. This can result in discomfort, visual disturbance, and potentially damage to the ocular surface. It is often associated with inflammation of the conjunctiva and the cornea. The symptoms may include dryness, scratchiness, burning, foreign body sensation, pain, redness, blurred vision, and light sensitivity.

Keratoconjunctivitis is a medical term that refers to the inflammation of both the cornea (the clear, outer layer at the front of the eye) and the conjunctiva (the mucous membrane that covers the inner surface of the eyelids and the white part of the eye).

The condition can cause symptoms such as redness, pain, sensitivity to light, watery eyes, and a gritty or burning sensation in the eyes. Keratoconjunctivitis can be caused by various factors, including viral or bacterial infections, allergies, or environmental irritants like dust, smoke, or chemical fumes.

Treatment for keratoconjunctivitis depends on the underlying cause of the condition and may include medications such as antibiotics, antivirals, or anti-inflammatory agents to reduce inflammation and relieve symptoms. In some cases, artificial tears or lubricants may also be recommended to help keep the eyes moist and comfortable.

In medical terms, "tears" are a clear, salty liquid that is produced by the tear glands (lacrimal glands) in our eyes. They serve to keep the eyes moist, protect against dust and other foreign particles, and help to provide clear vision by maintaining a smooth surface on the front of the eye. Tears consist of water, oil, and mucus, which help to prevent evaporation and ensure that the tears spread evenly across the surface of the eye. Emotional or reflexive responses, such as crying or yawning, can also stimulate the production of tears.

The lacrimal apparatus is a complex system in the eye that produces, stores, and drains tears. It consists of several components including:

1. Lacrimal glands: These are located in the upper outer part of the eyelid and produce tears to keep the eye surface moist and protected from external agents.
2. Tear ducts (lacrimal canaliculi): These are small tubes that drain tears from the surface of the eye into the lacrimal sac.
3. Lacrimal sac: This is a small pouch-like structure located in the inner part of the eyelid, which collects tears from the tear ducts and drains them into the nasolacrimal duct.
4. Nasolacrimal duct: This is a tube that runs from the lacrimal sac to the nose and drains tears into the nasal cavity.

The lacrimal apparatus helps maintain the health and comfort of the eye by keeping it lubricated, protecting it from infection, and removing any foreign particles or debris.

Infectious keratoconjunctivitis (IKC) is a medical condition that refers to an inflammation of both the cornea (kerato-) and the conjunctiva (-conjunctivitis), which are the transparent membranes that cover the front part of the eye. IKC is caused by an infection, most commonly due to viral or bacterial pathogens.

The viral form of IKC is often caused by adenoviruses and can be highly contagious, spreading through respiratory droplets, contaminated surfaces, or direct contact with the infected person's eyes. The symptoms may include redness, watery eyes, sensitivity to light, a gritty or burning sensation in the eyes, and discharge. In some cases, there might be swollen lymph nodes near the ear or neck.

Bacterial IKC can result from various bacterial species, such as Staphylococcus aureus, Streptococcus pneumoniae, or Haemophilus influenzae. The symptoms of bacterial IKC are similar to those of viral IKC but may also include more purulent discharge and potential complications like corneal ulcers or abscesses.

Treatment for infectious keratoconjunctivitis depends on the underlying cause. Viral IKC typically resolves within 1-3 weeks without specific treatment, although cool compresses and artificial tears may help alleviate symptoms. Bacterial IKC may require antibiotic eye drops or ointments to clear the infection and prevent complications. In both cases, good hygiene practices are essential to prevent spreading the infection to others.

Sjögren's syndrome is a chronic autoimmune disorder in which the body's immune system mistakenly attacks its own moisture-producing glands, particularly the tear and salivary glands. This can lead to symptoms such as dry eyes, dry mouth, and dryness in other areas of the body. In some cases, it may also affect other organs, leading to a variety of complications.

There are two types of Sjögren's syndrome: primary and secondary. Primary Sjögren's syndrome occurs when the condition develops on its own, while secondary Sjögren's syndrome occurs when it develops in conjunction with another autoimmune disease, such as rheumatoid arthritis or lupus.

The exact cause of Sjögren's syndrome is not fully understood, but it is believed to involve a combination of genetic and environmental factors. Treatment typically focuses on relieving symptoms and may include artificial tears, saliva substitutes, medications to stimulate saliva production, and immunosuppressive drugs in more severe cases.

The conjunctiva is the mucous membrane that lines the inner surface of the eyelids and covers the front part of the eye, also known as the sclera. It helps to keep the eye moist and protected from irritants. The conjunctiva can become inflamed or infected, leading to conditions such as conjunctivitis (pink eye).

Fluorophotometry is a medical diagnostic technique that measures the concentration of fluorescein dye in various tissues, particularly the eye. This technique utilizes a specialized instrument called a fluorophotometer which emits light at a specific wavelength that causes the fluorescein to emit light at a longer wavelength. The intensity of this emitted light is then measured and used to calculate the concentration of fluorescein in the tissue.

Fluorophotometry is often used in ophthalmology to assess the permeability of the blood-retinal barrier, which can be helpful in diagnosing and monitoring conditions such as diabetic retinopathy, age-related macular degeneration, and uveitis. It may also have applications in other medical fields for measuring the concentration of fluorescent markers in various tissues.

Lissamine Green Dyes are a type of diagnostic dye used in ophthalmology to assess the health and integrity of the tear film and the corneal surface. These dyes have a green color and are often used in conjunction with other dyes like fluorescein. When applied to the eye, Lissamine Green Dyes selectively stain areas of the eye that have been damaged or disrupted, such as areas of dryness, irritation, or inflammation.

The dye binds to denatured proteins and cellular debris on the surface of the eye, highlighting any abnormalities in the tear film or corneal epithelium. Lissamine Green Dyes can help diagnose conditions such as dry eye syndrome, exposure keratopathy, and corneal abrasions. The dye is generally considered safe for use in diagnostic procedures, but it should be used with caution and according to proper protocols to minimize any potential risks or discomfort to the patient.

Fluorescein is not a medical condition or term, but rather a diagnostic dye used in various medical tests and procedures. Medically, it is referred to as Fluorescein Sodium, a fluorescent compound that absorbs light at one wavelength and emits light at another longer wavelength when excited.

In the field of ophthalmology (eye care), Fluorescein is commonly used in:

1. Fluorescein angiography: A diagnostic test to examine blood flow in the retina and choroid, often used to diagnose and manage conditions like diabetic retinopathy, age-related macular degeneration, and retinal vessel occlusions.
2. Tear film assessment: Fluorescein dye is used to evaluate the quality of tear film and diagnose dry eye syndrome by observing the staining pattern on the cornea.
3. Corneal abrasions/foreign body detection: Fluorescein dye can help identify corneal injuries, such as abrasions or foreign bodies, under a cobalt blue light.

In other medical fields, fluorescein is also used in procedures like:

1. Urinary tract imaging: To detect urinary tract abnormalities and evaluate kidney function.
2. Lymphangiography: A procedure to visualize the lymphatic system.
3. Surgical navigation: In some surgical procedures, fluorescein is used as a marker for better visualization of specific structures or areas.

Allergic conjunctivitis is a type of conjunctivitis (inflammation of the conjunctiva, the membrane that covers the white part of the eye and the inner surface of the eyelids) caused by an allergic reaction to substances such as pollen, dust mites, or pet dander. It is often characterized by redness, itching, watering, and swelling of the eyes. In some cases, the eyes may also become sensitive to light. Allergic conjunctivitis is not contagious and can be treated with medications such as antihistamines, decongestants, or mast cell stabilizers.

Xerophthalmia is a medical condition characterized by dryness of the conjunctiva and cornea due to vitamin A deficiency. It can lead to eye damage, including night blindness (nyctalopia) and, if left untreated, potentially irreversible blindness. Xerophthalmia is often associated with malnutrition and affects children in low-income countries disproportionately.

Xerostomia is a medical term that describes the subjective feeling of dryness in the mouth due to decreased or absent saliva flow. It's also commonly referred to as "dry mouth." This condition can result from various factors, including medications, dehydration, radiation therapy, Sjögren's syndrome, and other medical disorders. Prolonged xerostomia may lead to oral health issues such as dental caries, oral candidiasis, and difficulty with speaking, chewing, and swallowing.

Rose Bengal is not a medical term per se, but a chemical compound that is used in various medical applications. It's a dye that is primarily used as a diagnostic stain to test for damaged or denatured cells, particularly in the eye and mouth. In ophthalmology, a Rose Bengal stain is used to identify damage to the cornea's surface, while in dentistry, it can help detect injured oral mucosa or lesions.

The dye works by staining dead or damaged cells more intensely than healthy ones, allowing healthcare professionals to visualize and assess any abnormalities or injuries. However, it is important to note that Rose Bengal itself is not a treatment for these conditions; rather, it is a diagnostic tool used to inform appropriate medical interventions.

'Neisseria sicca' is not typically considered a medical condition or disease. Neisseria sicca is actually a type of commensal bacteria that naturally resides in the human mouth and upper respiratory tract. It belongs to the genus Neisseria, which includes several species of gram-negative diplococci.

Neisseria sicca is often considered nonpathogenic, meaning it does not usually cause illness or disease. However, some studies suggest that it may have the potential to become opportunistic pathogens under certain circumstances, such as in individuals with weakened immune systems. In general, though, Neisseria sicca is not a significant medical concern and is not typically the focus of medical treatment.

Dry eye syndrome, also known as keratoconjunctivitis sicca, is a condition characterized by insufficient lubrication and moisture of the eyes. This occurs when the tears produced by the eyes are not sufficient in quantity or quality to keep the eyes moist and comfortable. The medical definition of dry eye syndromes includes the following symptoms:

1. A gritty or sandy sensation in the eyes
2. Burning or stinging sensations
3. Redness and irritation
4. Blurred vision that improves with blinking
5. Light sensitivity
6. A feeling of something foreign in the eye
7. Stringy mucus in or around the eyes
8. Difficulty wearing contact lenses
9. Watery eyes, which may seem contradictory but can be a response to dryness
10. Eye fatigue and discomfort after prolonged screen time or reading

The causes of dry eye syndromes can include aging, hormonal changes, certain medical conditions (such as diabetes, rheumatoid arthritis, lupus, Sjogren's syndrome), medications (antihistamines, decongestants, antidepressants, birth control pills), environmental factors (dry air, wind, smoke, dust), and prolonged screen time or reading.

Treatment for dry eye syndromes depends on the severity of the condition and its underlying causes. It may include artificial tears, lifestyle changes, prescription medications, and in some cases, surgical procedures to improve tear production or drainage.

Ophthalmic solutions are sterile, single-use or multi-dose preparations in a liquid form that are intended for topical administration to the eye. These solutions can contain various types of medications, such as antibiotics, anti-inflammatory agents, antihistamines, or lubricants, which are used to treat or prevent ocular diseases and conditions.

The pH and osmolarity of ophthalmic solutions are carefully controlled to match the physiological environment of the eye and minimize any potential discomfort or irritation. The solutions may be packaged in various forms, including drops, sprays, or irrigations, depending on the intended use and administration route.

It is important to follow the instructions for use provided by a healthcare professional when administering ophthalmic solutions, as improper use can lead to eye injury or reduced effectiveness of the medication.

"Moraxella" is a genus of gram-negative, aerobic bacteria that are commonly found on the mucous membranes of humans and animals. They are non-motile and catalase-positive. Some species of Moraxella can cause infections in humans, such as M. catarrhalis, which is a common cause of respiratory tract infections like bronchitis and otitis media (middle ear infection) in children. Another species, M. nonliquefaciens, can be found on the skin and mucous membranes of humans and animals, but it's not considered to be pathogenic.

It is worth noting that Moraxella genus was previously classified under the name Neisseria, but based on genetic and biochemical evidence, they are now considered separate genera.

Viral conjunctivitis is an inflammation of the conjunctiva, the thin membrane that covers the white part of the eye (sclera) and the inner surface of the eyelids, caused by a viral infection. The condition is often characterized by redness, watering, gritty or burning sensation in the eyes, and a clear, watery discharge. In some cases, it may also cause swelling of the eyelids and light sensitivity.

The most common viruses that can cause conjunctivitis are adenoviruses, which are responsible for about 65-90% of all viral conjunctivitis cases. Other viruses that can cause the condition include herpes simplex virus, varicella-zoster virus (which causes chickenpox and shingles), and picornaviruses.

Viral conjunctivitis is highly contagious and can spread easily through direct contact with infected individuals or contaminated surfaces. It typically affects one eye first and then spreads to the other eye within a few days. The condition usually resolves on its own within 1-2 weeks, although in some cases it may take longer to clear up completely.

There is no specific treatment for viral conjunctivitis, and antibiotics are not effective against viral infections. However, cool compresses and artificial tears can help alleviate symptoms such as discomfort and dryness. It is important to practice good hygiene, such as washing hands frequently and avoiding touching the eyes, to prevent the spread of the virus to others.

The cornea is the clear, dome-shaped surface at the front of the eye. It plays a crucial role in focusing vision. The cornea protects the eye from harmful particles and microorganisms, and it also serves as a barrier against UV light. Its transparency allows light to pass through and get focused onto the retina. The cornea does not contain blood vessels, so it relies on tears and the fluid inside the eye (aqueous humor) for nutrition and oxygen. Any damage or disease that affects its clarity and shape can significantly impact vision and potentially lead to blindness if left untreated.

Topical administration refers to a route of administering a medication or treatment directly to a specific area of the body, such as the skin, mucous membranes, or eyes. This method allows the drug to be applied directly to the site where it is needed, which can increase its effectiveness and reduce potential side effects compared to systemic administration (taking the medication by mouth or injecting it into a vein or muscle).

Topical medications come in various forms, including creams, ointments, gels, lotions, solutions, sprays, and patches. They may be used to treat localized conditions such as skin infections, rashes, inflammation, or pain, or to deliver medication to the eyes or mucous membranes for local or systemic effects.

When applying topical medications, it is important to follow the instructions carefully to ensure proper absorption and avoid irritation or other adverse reactions. This may include cleaning the area before application, covering the treated area with a dressing, or avoiding exposure to sunlight or water after application, depending on the specific medication and its intended use.

Adenoviruses are a group of viruses that commonly cause respiratory infections such as bronchitis, pneumonia, and fevers in humans. They can also cause conjunctivitis (pink eye), croup, and stomach and intestinal inflammation (gastroenteritis). Adenovirus infections are most common in children, but people of any age can be infected. The viruses spread through the air when an infected person coughs or sneezes, or through contact with contaminated surfaces or objects. There is no specific treatment for adenovirus infections, and most people recover on their own within a week or two. However, some people may develop more severe illness, particularly those with weakened immune systems. Preventive measures include frequent hand washing and avoiding close contact with infected individuals. Some adenoviruses can also cause serious diseases in people with compromised immune systems, such as transplant recipients and people undergoing cancer treatment. There are vaccines available to prevent some types of adenovirus infections in military recruits, who are at higher risk due to close living quarters and stress on the immune system from basic training.

Adenoviridae infections refer to diseases caused by members of the Adenoviridae family of viruses, which are non-enveloped, double-stranded DNA viruses. These viruses can infect a wide range of hosts, including humans, animals, and birds. In humans, adenovirus infections can cause a variety of symptoms, depending on the specific type of virus and the age and immune status of the infected individual.

Common manifestations of adenovirus infections in humans include:

1. Respiratory illness: Adenoviruses are a common cause of respiratory tract infections, such as bronchitis, pneumonia, and croup. They can also cause conjunctivitis (pink eye) and pharyngoconjunctival fever.
2. Gastrointestinal illness: Some types of adenoviruses can cause diarrhea, vomiting, and abdominal pain, particularly in children and immunocompromised individuals.
3. Genitourinary illness: Adenoviruses have been associated with urinary tract infections, hemorrhagic cystitis, and nephritis.
4. Eye infections: Epidemic keratoconjunctivitis is a severe form of conjunctivitis caused by certain adenovirus types.
5. Central nervous system infections: Adenoviruses have been linked to meningitis, encephalitis, and other neurological disorders, although these are rare.

Transmission of adenoviruses typically occurs through respiratory droplets, contaminated surfaces, or contaminated water. Preventive measures include good hygiene practices, such as handwashing and avoiding close contact with infected individuals. There is no specific treatment for adenovirus infections, but supportive care can help alleviate symptoms. In severe cases or in immunocompromised patients, antiviral therapy may be considered.

Conjunctivitis is an inflammation or infection of the conjunctiva, a thin, clear membrane that covers the inner surface of the eyelids and the outer surface of the eye. The condition can cause redness, itching, burning, tearing, discomfort, and a gritty feeling in the eyes. It can also result in a discharge that can be clear, yellow, or greenish.

Conjunctivitis can have various causes, including bacterial or viral infections, allergies, irritants (such as smoke, chlorine, or contact lens solutions), and underlying medical conditions (like dry eye or autoimmune disorders). Treatment depends on the cause of the condition but may include antibiotics, antihistamines, anti-inflammatory medications, or warm compresses.

It is essential to maintain good hygiene practices, like washing hands frequently and avoiding touching or rubbing the eyes, to prevent spreading conjunctivitis to others. If you suspect you have conjunctivitis, it's recommended that you consult an eye care professional for a proper diagnosis and treatment plan.

"Neisseria" is a genus of gram-negative, aerobic bacteria that are commonly found as part of the normal flora in the human body, particularly in the mouth, nose, and genital tract. Some species of Neisseria can cause diseases in humans, the most well-known being Neisseria meningitidis (meningococcus), which can cause meningitis and sepsis, and Neisseria gonorrhoeae (gonococcus), which causes the sexually transmitted infection gonorrhea. These bacteria are named after German physician and bacteriologist Albert Neisser, who first described them in the late 19th century.

Dacryocystitis is a medical condition that refers to the inflammation of the lacrimal sac, which is a small sac-like structure located in the inner corner of the eye near the nose. The lacrimal sac is responsible for draining tears from the eye into the nasal cavity.

Dacryocystitis can occur as a result of an infection or obstruction in the tear drainage system, leading to the accumulation of tears and other debris in the lacrimal sac. This can cause symptoms such as redness, swelling, pain, and tenderness in the affected area, as well as discharge from the eye or nose.

In some cases, dacryocystitis may be treated with antibiotics to clear up any infection. In more severe cases, surgery may be required to remove any blockages and improve tear drainage. If left untreated, dacryocystitis can lead to complications such as the formation of an abscess or damage to the eye.

Mycoplasma conjunctivae is a species of bacteria that belongs to the class Mollicutes and the genus Mycoplasma. It is known to cause infectious keratoconjunctivitis, an inflammation of the cornea and conjunctiva, in various animals such as sheep, goats, and wild ungulates (hoofed mammals).

This bacterium lacks a cell wall, which makes it resistant to many antibiotics that target cell wall synthesis. It can be transmitted through direct contact with infected animals or contaminated fomites (inanimate objects), making it a significant pathogen in veterinary medicine, particularly in intensive farming settings.

It is important to note that Mycoplasma conjunctivae does not infect humans and is not associated with any human diseases.

Adenoviruses, Human: A group of viruses that commonly cause respiratory illnesses, such as bronchitis, pneumonia, and croup, in humans. They can also cause conjunctivitis (pink eye), cystitis (bladder infection), and gastroenteritis (stomach and intestinal infection).

Human adenoviruses are non-enveloped, double-stranded DNA viruses that belong to the family Adenoviridae. There are more than 50 different types of human adenoviruses, which can be classified into seven species (A-G). Different types of adenoviruses tend to cause specific illnesses, such as respiratory or gastrointestinal infections.

Human adenoviruses are highly contagious and can spread through close personal contact, respiratory droplets, or contaminated surfaces. They can also be transmitted through contaminated water sources. Some people may become carriers of the virus and experience no symptoms but still spread the virus to others.

Most human adenovirus infections are mild and resolve on their own within a few days to a week. However, some types of adenoviruses can cause severe illness, particularly in people with weakened immune systems, such as infants, young children, older adults, and individuals with HIV/AIDS or organ transplants.

There are no specific antiviral treatments for human adenovirus infections, but supportive care, such as hydration, rest, and fever reduction, can help manage symptoms. Preventive measures include practicing good hygiene, such as washing hands frequently, avoiding close contact with sick individuals, and not sharing personal items like towels or utensils.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

Dry eye syndrome (keratoconjunctivitis sicca) is a common ocular surface disorder and is characterized by disruption of the ... "Keratoconjunctivitis, Sicca". The Merck Veterinary Manual. Merck & Co., Inc. Archived from the original on 2007-03-16. ... Artificial tears are a part of the topical therapy for keratoconjunctivitis sicca for animals such as dogs, cats and horses. ... Sjögren's syndrome "Keratoconjunctivitis, Sicca". eMedicine. WebMD, Inc. 2006-04-21. Archived from the original on 16 October ...
"Keratoconjunctivitis, Sicca". eMedicine. WebMD, Inc. January 27, 2010. Retrieved September 3, 2010. Ervin AM, Law A, Pucker AD ...
"Keratoconjunctivitis, Sicca". eMedicine. WebMD, Inc. January 27, 2010. Retrieved September 3, 2010. Bradley JC, Yang W, Bradley ...
Eye surgery Keratoconjunctivitis sicca "Tarsorrhaphy". Encyclopedia of Surgery. Archived from the original on 18 April 2015. ...
A disorder commonly found in Cavaliers is keratoconjunctivitis sicca, colloquially known as "dry eye". The usual cause of this ... "What is keratoconjunctivitis sicca (KCS)?". Canine Inherited Disorders Database. 11 May 2000. Retrieved 14 November 2009. ...
Acute promyelocytic leukemia Keratoconjunctivitis sicca Xerophthalmia Schwartz, Robert. "Dermatologic manifestations of Vitamin ...
Keratoconjunctivitis sicca (dry eye) is common in dogs. Symptoms include eye redness, a yellow or greenish discharge, ... Other eye conditions can cause corneal ulcers, such as entropion, distichia, corneal dystrophy, and keratoconjunctivitis sicca ... and keratoconjunctivitis sicca. Any bacterial infection is usually secondary. Eye proptosis is a condition resulting in forward ...
Keratoconjunctivitis sicca may occur due to secondary Sjögren's syndrome. Individuals with Felty's syndrome may also experience ...
"Neurturin-deficient mice develop dry eye and keratoconjunctivitis sicca". Investigative Ophthalmology & Visual Science. 44 (10 ... Lastly, a study also associated neurturin deficiency in mice with keratoconjunctivitis and dry eye. Evidence showing ...
Keratoconjunctivitis Keratoconjunctivitis sicca Keratomalacia, also caused by vitamin A deficiency. Grecia, Jo-ann G.; Yap, ... ISBN 978-971-07-3864-9. Solans, R.; Bosch, J.A.; Galofre, P.; others (2001), "Salivary and lacrimal gland dysfunction (sicca ...
... and certain topical medications are also causes of keratoconjunctivitis sicca. Persons with keratoconjunctivitis sicca have ... keratoconjunctivitis sicca, dysfunctional tear syndrome, lacrimal keratoconjunctivitis, evaporative tear deficiency, aqueous ... The phrase "keratoconjunctivitis sicca" means "dryness of the cornea and conjunctiva" in Latin Typical symptoms of dry eye ... Keratoconjunctivitis sicca can be caused by inadequate tear production from lacrimal hyposecretion. The aqueous tear layer is ...
It is also used as eye drops for keratoconjunctivitis sicca (dry eyes). Common side effects include high blood pressure, ... a topical emulsion of ciclosporin for treating inflammation caused by keratoconjunctivitis sicca (dry eye syndrome) has been ... Reinhard T (2000). "Lokales Cyclosporin A bei Nummuli nach Keratoconjunctivitis epidemica Eine Pilotstudie - Springer". Der ... persistent nummular keratitis following adenoviral keratoconjunctivitis, and as eye drops for treating dry eyes caused by ...
Transplantation of the autologous submandibular gland for most severe cases of keratoconjunctivitis sicca. Coauthors: Peter ...
Sjögren introduced the term keratoconjunctivitis sicca for the symptom of dry eyes (keratoconjunctivitis). In 1933, he ... The term "keratoconjunctivitis sicca" was coined by Sjögren himself and began to be identified as Sjögren's syndrome in ... Sjögren clarified that keratoconjunctivitis sicca, resulting from water deficiency, had no relation to xerophthalmia, resulting ... The hallmark symptom of Sjögren syndrome is dry mouth and keratoconjunctivitis sicca (dry eyes). Vaginal dryness, dry skin, and ...
Preliminary investigation for the treatment of keratoconjunctivitis sicca has been conducted in cellular models. Phase II ...
Optimmune: Ophthalmic ointment (ciclosporin) for the treatment of Pannis and Keratoconjunctivitis sicca in dogs. Orbax: Trade ...
They are prone to eye problems such as keratoconjunctivitis sicca (dry eyes), cataracts, and entropion. They sometimes get ...
... tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca". Veterinary Ophthalmology. 8 (4): 225 ... Tacrolimus solution, as drops, is sometimes prescribed by veterinarians for keratoconjunctivitis, and other dry eye maladies, ...
Replaced eyes have a higher rate of keratoconjunctivitis sicca and keratitis and often require lifelong treatment. If the ... Another possible complication is a form of redness or irritation called superior limbic keratoconjunctivitis, in which the area ...
The breed also suffers from another eye disease called keratoconjunctivitis sicca or dry eye syndrome (DES). Along with Kerry ...
In primary Sjögren syndrome (pSS) individuals have dry eyes (keratoconjunctivitis sicca) and a dry mouth (xerostomia). Based on ...
... tends to occur more often with dry eye syndrome (keratoconjunctivitis sicca), ... Superior limbic keratoconjunctivitis (SLK, Théodore's syndrome) is a disease of the eye characterized by episodes of recurrent ... "Superior limbic keratoconjunctivitis , Genetic and Rare Diseases Information Center (GARD) - an NCATS Program". rarediseases. ... "Superior Limbic Keratoconjunctivitis - EyeWiki". eyewiki.aao.org. Retrieved 2021-07-03. Theodore, F. H. (January 1963). " ...
Other ocular signs of FHV-1 infection include conjunctivitis, keratitis, keratoconjunctivitis sicca (decreased tear production ...
Other tests that may be necessary include a Schirmer's test for keratoconjunctivitis sicca and an analysis of facial nerve ... and keratoconjunctivitis sicca (dry eye). Many micro-organisms cause infective corneal ulcer. Among them are bacteria ( ... of corneal ulceration which predominantly occurs only within a particular region of Australia Vernal keratoconjunctivitis, a ...
Other tests that may be necessary include a Schirmer's test for keratoconjunctivitis sicca and an analysis of facial nerve ... Other eye conditions can cause corneal ulcers, such as entropion, distichiae, corneal dystrophy, and keratoconjunctivitis sicca ...
Keratoconjunctivitis sicca, known in the vernacular as dry eye, is a very common disorder of the tear film. Despite the eyes ...
... sicca is used when the inflammation is due to dryness. ("Sicca" means "dryness" in medical contexts.) It ... The term "vernal keratoconjunctivitis" (VKC) is used to refer to keratoconjunctivitis occurring in spring, and is usually ... eMedicine - on Atopic keratoconjunctivitis eMedicine - on Epidemic keratoconjunctivitis v t e (Articles with short description ... "Atopic keratoconjunctivitis" is one manifestation of atopy. "Epidemic keratoconjunctivitis" is caused by an adenovirus ...
Computer vision syndrome Digital media use and mental health Keratoconjunctivitis sicca Musculoskeletal disorder "Electronic ...
Nell B, Walde I, Billich A, Vit P, Meingassner J (2005). "The effect of topical pimecrolimus on keratoconjunctivitis sicca and ...
... is characterized by keratoconjunctivitis sicca (dry eyes) and the resulting scarring, fibrosis, ...
... or keratitis sicca, is a multifactorial disease of the tears and the ocular surface that results in discomfort, visual ... encoded search term (Dry Eye Disease (Keratoconjunctivitis Sicca)) and Dry Eye Disease (Keratoconjunctivitis Sicca) What to ... Dry eye disease (DED), also known as dry eye syndrome (DES), keratoconjunctivitis sicca (KCS), and keratitis sicca, is a ... Dry Eye Disease (Keratoconjunctivitis Sicca). Updated: Jun 06, 2023 * Author: Trent Tsun-Kang Chiang, MD, MS; Chief Editor: ...
If you have any questions regarding keratoconjunctivitis sicca (KCS), please call us at Eye Care for Animals. ... Keratoconjunctivitis sicca is due to dysfunction in the corneal tear film, and it results in patchy, dry areas across the ... Another cause of keratoconjunctivitis sicca is a toxic effect produced by some sulfa-containing antibiotics and non-steroidal ... Most patients with keratoconjunctivitis sicca do well if medications are administered on a timely basis. In cases where ...
Keratoconjunctivitis Sicca (Dry Eye) market report contains a holistic evaluation of the market including a comprehensive ... Keratoconjunctivitis Sicca Clinical Trials Market Report Overview The Keratoconjunctivitis Sicca (Dry Eye) clinical trial ... Keratoconjunctivitis Sicca (Dry Eye). GlobalDatas reports offer expert analysis, insights and opinions to companies in the ... Keratoconjunctivitis Sicca Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update ...
Canine keratoconjunctivitis sicca (KCS) is a common ocular disease characterized by a variable diminution of the aqueous layer ... Eleven cases of severe and unilateral keratoconjunctivitis sicca in young Yorkshire Terriers are presented. All of them showed ... Severe, Unilateral, and Non-Responsive Keratoconjunctivitis Sicca in Eleven Young Yorkshire Terriers ...
Tips for optometrists on coding for meibomian gland disease and Keratoconjunctivitis Sicca including codes to use. ... H16.222 Keratoconjunctivitis Sicca, Not Specified as Sjogrens, Left Eye. H16.223 Keratoconjunctivitis Sicca, Not Specified as ... For the patients Keratoconjunctivitis Sicca, you continue Cyclosporin 0.05% BID OU and decide to insert surface mount plugs ... Related Items:coding and billing, coding for dry eye, coding for Keratoconjunctivitis Sicca, coding for meimbomian gland ...
Bluegrass Veterinary Vision | 2563 Todds Point Road Simpsonville KY 40067
Keratoconjunctivitis sicca. Keratoconjunctivitis sicca (KCS), also known as dry eyes, is one of the most common. reasons a ...
KERATOCONJUNCTIVITIS SICCA Keratoconjunctivitis sicca (KCS) is often used synonymously with the general term dry eye. KCS is ... Keratoconjunctivitis sicca. KERATOCONJUNCTIVITIS SICCA. Keratoconjunctivitis sicca (KCS) is often used synonymously with the ...
... (KCS), also called keratitis sicca,[1] sicca syndrome,[1] xerophthalmia,[1] dry eye syndrome (DES),[ ... Keratoconjunctivitis sicca is Latin and its literal translation is "dryness of the cornea and conjunctiva". It may be helpful ... to know that "sicca" is part of the English word "desiccate.". Typical symptoms of keratoconjunctivitis are dryness, burning[3 ...
Keratoconjunctivitis Sicca (KCS) admin 2013-12-24T23:48:03-05:00 Tears are essential to keeping the eyes moist and healthy by ... Keratoconjunctivitis Sicca (KCS) is a common eye condition where the tear glands do not produce enough of the water portion of ...
Keratoconjunctivitis Sicca - Etiology, pathophysiology, symptoms, signs, diagnosis & prognosis from the MSD Manuals - Medical ... Keratoconjunctivitis Sicca (Dry Eyes; Keratitis Sicca). By Melvin I. Roat , MD, FACS, Sidney Kimmel Medical College at Thomas ... the patient has aqueous tear-deficient keratoconjunctivitis sicca. With evaporative keratoconjunctivitis sicca, the Schirmer ... Etiology of Keratoconjunctivitis Sicca The conjunctival and corneal surface epithelial cells need to be hydrated. If there is ...
Keratoconjunctivitis sicca, or KCS, is a condition in which the eyes fail to produce adequate tears or retain a protective ... https://www.medicalnewstoday.com/articles/keratoconjunctivitis-sicca-symptoms-and-treatment. *https://www.aao.org/preferred- ...
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. ...
New treatment for dry eye syndrome (keratoconjunctivitis sicca) Researchers in the department of ophthalmology at the ...
Keratoconjunctivitis Sicca is a regular condition of the eye that happens once the tear glands stop manufacturing enough tears ... Keratoconjunctivitis sicca (KCS) as a medical term means swelling of the cornea and its close environs from drying. Dry eye in ... Keratoconjunctivitis Sicca in dogs is commonly caused by some of the following:. *Immune-mediated diseases that damage the tear ... Complete Guide to Keratoconjunctivitis Sicca (KCS) - Symptoms, Breed Specific, Stem Cell Treatment. *In Dogs Archives, Pet ...
Dry eye syndrome (keratoconjunctivitis sicca) is a common ocular surface disorder and is characterized by disruption of the ... "Keratoconjunctivitis, Sicca". The Merck Veterinary Manual. Merck & Co., Inc. Archived from the original on 2007-03-16. ... Artificial tears are a part of the topical therapy for keratoconjunctivitis sicca for animals such as dogs, cats and horses. ... Sjögrens syndrome "Keratoconjunctivitis, Sicca". eMedicine. WebMD, Inc. 2006-04-21. Archived from the original on 16 October ...
RESULTS: Patients with keratoconjunctivitis sicca had a mean straylight OD of log(s) = 1.36 ± 0.19 SD and OS of log(s) = 1.45 ... CONCLUSIONS: Keratoconjunctivitis sicca leads to increased straylight. However, this increase was not correlated to the amount ... METHODS: Straylight was measured in 16 patients with severe keratoconjunctivitis sicca using the Oculus C-Quant. In 9 of these ... PURPOSE: (1) To qualify complaints of quality of vision in patients with (severe) keratoconjunctivitis sicca by examining ...
Keratoconjunctivitis sicca. *Keratoconjunctivitis sicca-xerostomia. *Secreto-inhibitor-xerodermostenosis. *Sicca syndrome. * ...
Keratoconjunctivitis sicca (Dry Eye). Keratoconjunctivitis sicca is a condition in which there is inadequate production of ... Treatment for Keratoconjunctivitis Sicca. Keratoconjunctivitis sicca is treated with artificial tears (eye drops that are ... The cornea can also be damaged by a condition called dog dry eye or Keratoconjunctivitis sicca. ...
Keratoconjunctivitis sicca. PM. Proximal muscle weakness. Respiratory muscle failure. N/A. N/A ...
... and certain topical medications are also causes of keratoconjunctivitis sicca.[14] Persons with keratoconjunctivitis sicca have ... "Keratoconjunctivitis Sicca". The Merck Manual, Home Edition. Merck & Co. 2003-02-01. Archived from the original on 2006-11-12. ... Dry eye syndrome, also known as keratoconjunctivitis sicca, is the condition of having dry eyes.[2] Symptoms include dryness in ... keratoconjunctivitis sicca, dysfunctional tear syndrome, lacrimal keratoconjunctivitis, evaporative tear deficiency, aqueous ...
Keratoconjunctivitis Sicca. Cequa, Restasis, Vevye. Indicated to increase tear production associated with keratoconjunctivitis ... Indicated to increase tear production associated with keratoconjunctivitis sicca (dry eye). *Instill 1 drop BID in each eye ~12 ... Keratoconjunctivitis. Orphan designation for treatment of herpes simplex virus stromal keratitis. Orphan sponsor. *NOVAGALI ... Indicated for vernal keratoconjunctivitis (VKC) in children and adults. Instill 1 drop QID (morning, noon, afternoon, and ...
B: Keratoconjunctivitis sicca. C: Scleritis. D: Subconjunctival hemorrhage. Click here for the answer and critique. ...
Keratoconjunctivitis Sicca in dogs - otherwise known as Dry Eye Syndrome - is a chronic condition that occurs when significant ... keratoconjunctivitis sicca (KCS) Dry Eye In Dogs, Keratoconjunctivitis Sicca In Dogs, Keratoconjunctivitis Sicca Treatment ... Dog Breeds that Have Keratoconjunctivitis Sicca. Although keratoconjunctivitis sicca may be common in dogs, a few breeds are ... Keratoconjunctivitis Sicca can lead to blindness in breeds such as Dachshund and Pug, who are especially prone to this chronic ...
Keratoconjunctivitis happens when both your cornea and your conjunctiva become inflamed. There are several different types. ... Keratoconjunctivitis sicca: This condition is also called dry eye disease and happens in both eyes. If you have it, your eyes ... Treating very dry eyes if you have keratoconjunctivitis sicca may include:. *Putting a plug in the punctum (the small holes in ... What is keratoconjunctivitis?. Keratoconjunctivitis is the term for an eye condition that involves inflammation of both your ...
Extra-articular manifestations of RA include keratoconjunctivitis sicca, episcleritis, interstitial lung disease, pulmonary ... Keratoconjunctivitis sicca. Secondary Sjögren syndrome, dry mouth may also occur. Peripheral ulcerative keratitis. More severe ... most commonly skin nodules and keratoconjunctivitis sicca.12 More recent studies on multiethnic populations with RA in Korea ...
Sicca manifestations are treated symptomatically through administration of topical therapies, such as saliva substitutes and ... is based principally on the management of sicca features and systemic manifestations. ... Keratoconjunctivitis Sicca / drug therapy* * Keratoconjunctivitis Sicca / etiology * Male * Ophthalmic Solutions / ... Sicca manifestations are treated symptomatically through administration of topical therapies, such as saliva substitutes and ...
Keratoconjunctivitis Sicca-Any advice?. My 8year old Lasa Apso has an ulcer in left eye along with Kerato conjuncitvitis Sicca ...

No FAQ available that match "keratoconjunctivitis sicca"

No images available that match "keratoconjunctivitis sicca"